TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23490397

Group type: EXPERIMENTAL
Intervention: Single-tooth implants
Number of subjects: 25

Group type: COMPARATOR
Intervention: Natural teeth
Number of subjects: 25
Study: 21404051

Group type: COMPARATOR
Intervention: Mediterranean diet (Med diet)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with CoQ (Med+CoQ diet)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saturated fatty acid‐rich diet (SFA diet)
Number of subjects: 20
Study: 19942722

Group type: EXPERIMENTAL
Intervention: Acupuncture (n = 5)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Reflexology (n = 4)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Music therapy (n = 4)
Number of subjects: 13
Study: 21665421

Group type: EXPERIMENTAL
Intervention: Axillary lymph node clearance (ALNC)
Number of subjects: 625

Group type: COMPARATOR
Intervention: No axillary lymph node clearance (no-Ax)
Number of subjects: 625
Study: 15983684

Group type: EXPERIMENTAL
Intervention: Closure of the peritoneum
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nonclosure of the peritoneum
Number of subjects: 79
Study: 12512851

Group type: EXPERIMENTAL
Intervention: Invulnerability undermined (IU) condition
Number of subjects: 128

Group type: COMPARATOR
Intervention: Demand characteristic control (DCC) condition
Number of subjects: 128
Study: 10412777

Group type: EXPERIMENTAL
Intervention: Short-term intensive therapy (SIT)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Long-term intermittent therapy (LIT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Before SIT
Number of subjects: 15

Group type: COMPARATOR
Intervention: After SIT
Number of subjects: 15
Study: 7718750

Group type: EXPERIMENTAL
Intervention: Propofol-fentanyl (PF) anesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isoflurane-fentanyl (IF) anesthesia
Number of subjects: 30
Study: 2202852

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 64
Study: 6456668

Group type: EXPERIMENTAL
Intervention: Intravenous mezlocillin (16 gm/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ampicillin (8 gm/day)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Clindamycin (2 gm/day) added if patients failed to improve within 48 hours
Number of subjects: 70
Study: 29282336

Group type: EXPERIMENTAL
Intervention: CSF neurofilament light chain (NfL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CSF phosphorylated tau 181 (p-tau)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CSF tau
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CSF NfL/p-tau ratio
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CSF NfL
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: plasma NfL
Number of subjects: 50
Study: 26938333

Group type: EXPERIMENTAL
Intervention: Cilostazol 100 mg taken twice daily (n = 48)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) 100 mg daily (n = 41)
Number of subjects: 89
Study: 23640543

Group type: EXPERIMENTAL
Intervention: Counselor-Assisted Problem Solving (CAPS)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Internet resource comparison (IRC)
Number of subjects: 132
Study: 21820247

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 75-150 μg/d administration
Number of subjects: 8

Group type: COMPARATOR
Intervention: Tryptophan depletion (TD)
Number of subjects: 8
Study: 20163267

Group type: EXPERIMENTAL
Intervention: Alternative systemic agents to first‐line antimonials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced topical paromomycin preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thermotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunotherapy and immunomodulators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vitro studies of several drugs
Number of subjects: 0
Study: 18550360

Group type: EXPERIMENTAL
Intervention: Simple interventions
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Complex interventions
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Altruistic views
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Trial design factors
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Willingness to participate
Number of subjects: 101
Study: 15907756

Group type: EXPERIMENTAL
Intervention: Nurses and physicians' beliefs about dietary restrictions in epilepsy
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Personal experience with dietary restrictions
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Common foods reported by participants
Number of subjects: 250
Study: 12736841

Group type: EXPERIMENTAL
Intervention: Fast-reaction trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow-reaction trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 0
Study: 10482337

Group type: EXPERIMENTAL
Intervention: 10000 lx cool‐white fluorescent light (active condition)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 500 lx red fluorescent light (placebo condition)
Number of subjects: 14
Study: 7592271

Group type: EXPERIMENTAL
Intervention: Partial hospitalization programs
Number of subjects: 95

Group type: COMPARATOR
Intervention: Acute-care programs
Number of subjects: 95

Group type: COMPARATOR
Intervention: Long-term programs
Number of subjects: 95
Study: 1939943

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 743
Study: 7032457

Group type: EXPERIMENTAL
Intervention: Penicillamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (Penicillamine and Placebo)
Number of subjects: 0
Study: 30918320

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 50
Study: 28762878

Group type: EXPERIMENTAL
Intervention: Pitavastatin (4 mg daily)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 27288736

Group type: EXPERIMENTAL
Intervention: DSM‐5 ADHD symptom descriptors
Number of subjects: 78
Study: 25088629

Group type: EXPERIMENTAL
Intervention: Endoscopic cyclophotocoagulation (ECP) combined with phacoemulsification cataract extraction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Phacoemulsification cataract extraction alone
Number of subjects: 80
Study: 21415288

Group type: EXPERIMENTAL
Intervention: Nickel-titanium (NiTi) T-loop
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Titanium-molybdenum alloy (TMA) T-loop
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison of both T-loops
Number of subjects: 12
Study: 20927415

Group type: EXPERIMENTAL
Intervention: Vitremer + its own primer (3M ESPE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vitremer + Single Bond (3M ESPE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vitremer + Prime and Bond 2.1 (Dentsply)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (conventional treatment with RMGIC)
Number of subjects: 10
Study: 18485043

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs) such as paroxetine, fluoxetine, and sertraline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dapoxetine (short-acting SSRI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phosphodiesterase-5 inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical anaesthetics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tramadol (narcotic analgesic)
Number of subjects: 0
Study: 15747269

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.10‐0.25 microg/kg/min) with spinal morphine (4 microg/kg) and clonidine (1 microg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sufentanil (up to 3.5 microg/kg) with patient-controlled administration of intravenous morphine
Number of subjects: 40
Study: 12060975

Group type: EXPERIMENTAL
Intervention: Prostaglandin I2 (5 ng/kg/min)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (5 ng/kg/min)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (Control group H)
Number of subjects: 50
Study: 9747741

Group type: EXPERIMENTAL
Intervention: Bisphosphonate treatment in patients with severe hypercalcaemia (n=51, all treated except one).
Number of subjects: 212

Group type: COMPARATOR
Intervention: No bisphosphonate treatment in patients with severe hypercalcaemia (period 1).
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Patients with mild malignancy‐associated hypercalcaemia (not treated with bisphosphonates).
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Patients with moderate hypercalcaemia (not treated with bisphosphonates).
Number of subjects: 212
Study: 8605517

Group type: EXPERIMENTAL
Intervention: 3.5‐day dietary multibuffer supplement (PhosFuel)
Number of subjects: 20
Study: 2664173

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 788743

Group type: EXPERIMENTAL
Intervention: L-noradrenaline infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dopamine infusion
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control subjects (healthy subjects)
Number of subjects: 17
Study: 31385854

Group type: EXPERIMENTAL
Intervention: Stress condition (Trier Social Stress Test)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 51
Study: 29055668

Group type: COMPARATOR
Intervention: Single isocaloric liquid meal (L-SM) 600-kcal
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Solid meal (S-SM) 600-kcal
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Three 200-kcal minimeals (S)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Gastric pouch emptying
Number of subjects: 32
Study: 26658459

Group type: EXPERIMENTAL
Intervention: Nutrition and food safety education intervention (lectures 0.5 hour per week for two semesters)
Number of subjects: 478

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 478
Study: 23290927

Group type: EXPERIMENTAL
Intervention: Sonar-assisted search
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard search pattern
Number of subjects: 10
Study: 21292602

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise program for 16 weeks, three times per week, at 60 to 80 percent of the maximum heart rate.
Number of subjects: 40
Study: 18726150

Group type: EXPERIMENTAL
Intervention: Faux pas task (an advanced test of theory of mind)
Number of subjects: 0
Study: 16759923

Group type: EXPERIMENTAL
Intervention: Endometriosis (menstrual phase)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (normal pelvis)
Number of subjects: 35
Study: 15099277

Group type: EXPERIMENTAL
Intervention: Warfarin (target INR 2.0-2.5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Warfarin (target INR 2.8-4.2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin 160 mg d(‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin 75 mg d(‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined group (Aspirin + Warfarin)
Number of subjects: 0
Study: 11708708

Group type: EXPERIMENTAL
Intervention: Shoulder and hip flexor training (n = 14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nontraining control group (n = 12)
Number of subjects: 28
Study: 9803197

Group type: EXPERIMENTAL
Intervention: Antihypertensive drug therapy (diuretics or beta-adrenergic blockers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lifestyle modifications (not specified in detail)
Number of subjects: 0
Study: 7972630

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ritanserin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study: 2701002

Group type: EXPERIMENTAL
Intervention: Injectable thermoplasticized gutta-percha (Ultrafil)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lateral condensation technique (Control)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Experimental group with sealer
Number of subjects: 100
Study: 4558249

Group type: EXPERIMENTAL
Intervention: FTA-ABS test
Number of subjects: 1922

Group type: COMPARATOR
Intervention: RPCFT and automated reagin test
Number of subjects: 1922

Group type: COMPARATOR
Intervention: Cardiolipin WR
Number of subjects: 1922
Study: 30653851

Group type: EXPERIMENTAL
Intervention: Spironolactone/Pioglitazone/Metformin (SPIOMET), n = 24
Number of subjects: 51

Group type: COMPARATOR
Intervention: Oral Contraceptive (OC), n = 27
Number of subjects: 51

Group type: COMPARATOR
Intervention: Controls, n = 12
Number of subjects: 51
Study: 28985722

Group type: EXPERIMENTAL
Intervention: Referral card with contact details of services providing assistance and tips to increase safety behaviour
Number of subjects: 189

Group type: COMPARATOR
Intervention: Thank you card
Number of subjects: 189
Study: 24969566

Group type: EXPERIMENTAL
Intervention: 16 g/day Inulin-type fructans (ITF) for 3 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Maltodextrin (placebo) for 3 months
Number of subjects: 30
Study: 23036570

Group type: EXPERIMENTAL
Intervention: Time-domain optical coherence tomography
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Average RNFL loss
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Superior RNFL loss
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Visual field index improvement
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: RNFL improvement
Number of subjects: 487
Study: 21515997

Group type: EXPERIMENTAL
Intervention: Aroma massage using a mixture of lemon, lavender, rosemary, and cyprus oil, given 5 days a week for 4 weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Meridian massage at 9 acupoints influencing intestinal functions, given 5 days a week for 4 weeks
Number of subjects: 38
Study: 18025439

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy plus autologous stem-cell transplantation (HDCT)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Standard therapy (ST)
Number of subjects: 224
Study: 17049332

Group type: EXPERIMENTAL
Intervention: Artisan phakic intraocular lens (PIOL)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Artiflex phakic intraocular lens (PIOL)
Number of subjects: 31
Study: 11979994

Group type: EXPERIMENTAL
Intervention: Therapy for unstable coronary artery disease according to European Society of Cardiology guidelines
Number of subjects: 0
Study: 10086546

Group type: EXPERIMENTAL
Intervention: Propranolol (10 mg every 6 hours for 5 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7668913

Group type: EXPERIMENTAL
Intervention: Chloroquine treatment
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Deep coma (scoring 0-2)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Severe anaemia (haematocrit < 18%)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Asexual parasite counts
Number of subjects: 195
Study: 1754611

Group type: EXPERIMENTAL
Intervention: Bright white-light treatment (2,500 lux)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Dim red-light treatment (50 lux)
Number of subjects: 42
Study: 7031215

Group type: EXPERIMENTAL
Intervention: Three days of nitrofurantoin macrocrystals therapy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Ten days of nitrofurantoin macrocrystals therapy
Number of subjects: 49
Study: 6094104

Group type: EXPERIMENTAL
Intervention: Enalapril (10 to 40 mg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Hydrochlorothiazide plus propranolol (50 mg hydrochlorothiazide plus 80 to 240 mg propranolol/day)
Number of subjects: 15
Study: 31634898

Group type: EXPERIMENTAL
Intervention: Multipredictor nomogram combining neuroimaging features, CSF biomarkers, and clinical assessments.
Number of subjects: 290

Group type: COMPARATOR
Intervention: Nomogram using either Rad-sig or Aβ concentration as individual predictors.
Number of subjects: 290
Study: 29933749

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous immunoglobulin (IVIG) combined with high-dose aspirin
Number of subjects: 0
Study: 27111004

Group type: EXPERIMENTAL
Intervention: 3D computerized tutorial
Number of subjects: 63

Group type: COMPARATOR
Intervention: 3D images without computerized tutorial
Number of subjects: 63
Study: 24480335

Group type: EXPERIMENTAL
Intervention: Active somatosensory stimulation + task-specific training (TST)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham somatosensory stimulation + task-specific training (TST)
Number of subjects: 33
Study: 23194032

Group type: EXPERIMENTAL
Intervention: Annual mammographic screening starting at age 40
Number of subjects: 0
Study: 19779037

Group type: EXPERIMENTAL
Intervention: 15-microg/kg bolus followed by a 2-microg/kg/min infusion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 30-microg/kg bolus followed by a 4-microg/kg/min infusion
Number of subjects: 22
Study: 18822490

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol 4 g daily (Group 1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Rectal paracetamol in equipotential dose (Group 2)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No paracetamol (Group 3)
Number of subjects: 75
Study: 15677777

Group type: EXPERIMENTAL
Intervention: Pioglitazone (monotherapy)
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Pioglitazone plus sulfonylurea (combination therapy)
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Pioglitazone plus metformin (combination therapy)
Number of subjects: 940

Group type: COMPARATOR
Intervention: Metformin (monotherapy)
Number of subjects: 940

Group type: COMPARATOR
Intervention: Gliclazide (monotherapy)
Number of subjects: 940

Group type: COMPARATOR
Intervention: Metformin plus sulfonylurea (combination therapy)
Number of subjects: 940

Group type: COMPARATOR
Intervention: Gliclazide plus metformin (combination therapy)
Number of subjects: 940
Study: 11788698

Group type: EXPERIMENTAL
Intervention: StatLock securement
Number of subjects: 170

Group type: COMPARATOR
Intervention: Suture securement
Number of subjects: 170
Study: 10077377

Group type: EXPERIMENTAL
Intervention: Blood-based St. Thomas' cardioplegia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Crystalloid St. Thomas' cardioplegia
Number of subjects: 50
Study: 9238566

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 2248328

Group type: EXPERIMENTAL
Intervention: Topical cyclosporine (2% dilution in castor oil)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Castor oil alone (control)
Number of subjects: 11
Study: 6988713

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Tobramycin
Number of subjects: 258
Study: 30027388

Group type: EXPERIMENTAL
Intervention: Warm handoff (patient connected to quitline at bedside)
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Higher ratings of the tobacco treatment care transition
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Being older
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Higher transition of care ratings
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Use of cessation medication post-discharge
Number of subjects: 1054

Group type: COMPARATOR
Intervention: Fax referral (referral faxed to proactive quitline)
Number of subjects: 1054
Study: 26924303

Group type: EXPERIMENTAL
Intervention: 54 mg quercetin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 26506968

Group type: EXPERIMENTAL
Intervention: High-volume hemofiltration plus hemoperfusion (HVHF&HP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional treatment alone (control group)
Number of subjects: 20
Study: 22890639

Group type: EXPERIMENTAL
Intervention: Clazosentan (5 mg/h)
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1157
Study: 21221773

Group type: EXPERIMENTAL
Intervention: Exemestane (EXE) 25 mg daily for 12 months
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 98
Study: 19369178

Group type: EXPERIMENTAL
Intervention: Adalimumab plus Methotrexate (MTX)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Methotrexate (MTX) alone
Number of subjects: 47
Study: 17534968

Group type: EXPERIMENTAL
Intervention: Dietary intervention and house dust mite avoidance during the first 5 years of life
Number of subjects: 219
Study: 14988452

Group type: EXPERIMENTAL
Intervention: Plant sterols (S)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Plant stanols (SN)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 50:50 mixture of sterols and stanols (SSN)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Cornstarch (control)
Number of subjects: 14
Study: 11956614

Group type: EXPERIMENTAL
Intervention: Softcyte
Number of subjects: 315

Group type: COMPARATOR
Intervention: Endocyte
Number of subjects: 315
Study: 9971914

Group type: EXPERIMENTAL
Intervention: Omeprazole enteric-coated formulation A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omeprazole enteric-coated formulation B
Number of subjects: 0
Study: 7752863

Group type: EXPERIMENTAL
Intervention: Downhill running (DHR) at -10% grade for 60 min
Number of subjects: 10

Group type: COMPARATOR
Intervention: Level running (LR) at 0% grade for 60 min
Number of subjects: 10
Study: 2288396

Group type: EXPERIMENTAL
Intervention: Flunisolide aerosol (0.5 mg administered by a jet nebulizer twice daily for 2 months)
Number of subjects: 20
Study: 7275468

Group type: EXPERIMENTAL
Intervention: Total fasting
Number of subjects: 14

Group type: COMPARATOR
Intervention: Very-low-calorie diet (VLCD)
Number of subjects: 14
Study: 30116543

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 644

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 644
Study: 27196390

Group type: EXPERIMENTAL
Intervention: Foster family intervention (FFI)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 123
Study: 25007695

Group type: EXPERIMENTAL
Intervention: Ultrasound Group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Clinical Group
Number of subjects: 200
Study: 22362918

Group type: EXPERIMENTAL
Intervention: Vitamin D3
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 20185036

Group type: EXPERIMENTAL
Intervention: Distal protection (DP)
Number of subjects: 626

Group type: COMPARATOR
Intervention: Conventional treatment (CT)
Number of subjects: 626